http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010266679-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c98f57e6d39bee79bac9c90b02e91c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_febb12027f3cc468147f1cc7ced53b7f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2010-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5e03fb4c5a72674608d5b595866be77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d37d2b083575ce376657b8449c900750
publicationDate 2010-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2010266679-A1
titleOfInvention Crystalline modifications of n-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (l)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof
abstract The present invention relates to novel crystalline modifications of N-α-(2,4,6-triisopropylphenyl-sulfonyl)-3-hydroxyamidino-(L)-phenylalanine 4-ethoxy-carbonylpiperazide and/or salts thereof, which can be used as pharmaceutical agents, and to pharmaceutical compositions and pharmaceutical uses comprising these novel crystalline modifications.
priorityDate 2004-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004110831-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005245757-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129572203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20222086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87294560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68570519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229290426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229290424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229289479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87499972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246738715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228944774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68424248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228944772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242856946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91256733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228944312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87450175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129384955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247333221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68424092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128750386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87499718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128984259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90711766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68424091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227983982

Total number of triples: 79.